PCV20 COST EFFECTIVENESS OF ANTIHYPERTENSIVE MONO-THERAPYWITH PERINDOPRIL OR ENALAPRIL IN ELDERLY PATIENTS FROM THE THIRD PARTY PAYER PERSPECTIVE
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65802-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)65802-0/fulltext
Title :
PCV20 COST EFFECTIVENESS OF ANTIHYPERTENSIVE MONO-THERAPYWITH PERINDOPRIL OR ENALAPRIL IN ELDERLY PATIENTS FROM THE THIRD PARTY PAYER PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65802-0&doi=10.1016/S1098-3015(10)65802-0
First page :
Section Title :
Open access? :
No
Section Order :
171